Records containing: Unspecified Adult Solid Tumor, Protocol Specific
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-07-18A Phase I Study Of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, Triapine) In Combination With Cisplatin And Paclitaxel In Patients With Advanced And Metastatic Cancer
-
CLINICAL_TRIALS study record update · 2013-07-18An Open Label, Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP) in Cancer Patients Using a Single Daily Dose for Five Days
-
CLINICAL_TRIALS study record update · 2013-07-18A Phase I Study of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, Triapine) Administered Daily x 5 in Combination With Cisplatin
-
CLINICAL_TRIALS study record update · 2013-07-18A Phase I Trial of VNP4010M, A Novel Alkylating Agent for Patients With Advanced or Metastatic Cancer
-
CLINICAL_TRIALS study record update · 2013-07-18A Phase I Study of Bryostatin and Cisplatin in Patients With Advanced Cancer
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-07-11Phase I Evaluation of Topotecan in Combination With Paclitaxel and Carboplatin
-
CLINICAL_TRIALS study record update · 2013-07-10Phase I Study of Soblidotin and Gemcitabine in Patients With Locally Advanced or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-07-10Gemcitabine (10 mg/m2/Min) and Cisplatin: A Phase I Study
-
CLINICAL_TRIALS study record update · 2013-07-10A Phase I Study of DX-8951f (Exatecan Mesylate for Injection) in Patients With Renal Dysfunction
-
CLINICAL_TRIALS study record update · 2013-07-10Tailoring Nutrition Education for Low-Income Audiences
-
CLINICAL_TRIALS study record update · 2013-07-09A Randomized Phase III Trial of Amifostine vs. No Treatment for Platinum Induced Peripheral Neuropathy
-
CLINICAL_TRIALS study record update · 2013-07-09Phase I Dose Escalation Study of UCN-01 (NSC 638850) Plus Cisplatin in Advanced Malignant Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-07-03A Phase I/IIA Dose-Escalating Trial of BCL-2 Antisense (G3139) Treatment for Patients With Androgen-Independent Prostate Cancer or Other Advanced Solid Tumor Malignancies
-
CLINICAL_TRIALS study record update · 2013-07-02A Phase I Trial of Gemcitabine Followed by a Short Infusion of Flavopiridol in Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-07-02Phase I Trial of Vorinostat (NSC-701852, Suberoylanilide Hydroxamic Acid) and Doxorubicin (NSC-123127, Adriamycin)
-
CLINICAL_TRIALS study record update · 2013-07-01A Phase 1 Study of UCN-01 in Combination With Carboplatin in Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-06-27A Phase I Dose-Escalation Study of Topotecan and Ifosfamide in Patients With Refractory Non-Hematologic Malignancies.
-
CLINICAL_TRIALS study record update · 2013-06-26Phase I Evaluation of Green Tea Extract in Adults With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-06-26Use of Weekly One Hour Paclitaxel Infusion With Dose Escalation for Recurrent and Resistant Cancers, Using Amifostine as a Cytoprotector
-
CLINICAL_TRIALS study record update · 2013-06-26A Phase I Pharmacokinetic and Pharmacodynamic Study of 17-Allylamino-17-Demethoxygeldanamycin (17-AAG) (NSC 330507) Via Intravenous Administration in Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2013-06-26Phase I Bridging Trial of TG4010 as Antigen-Specific Immunotherapy in Patients With MUC-1 Positive Advanced Cancer
-
CLINICAL_TRIALS study record update · 2013-06-26Phase I and Clinical Pharamcologic Study of 10-Propargyl-10-Deazaaminopterin (PDX) in Combination With Probenecid in Adults With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-06-25A Pharmacokinetic Study Evaluating the Safety, Tolerability and Maximally Tolerated Dose of 7-Day Continuous Infusions of L-778,123 in Patients With Recurrent of Refractory Solid Malignancies
-
CLINICAL_TRIALS study record update · 2013-06-25Phase I Study of R031-7453, a Novell Cell Cycle Inhibitor, Administered as Escalating Oral Doses in Adults With Solid Tumors: 4-Day Schedule
-
CLINICAL_TRIALS study record update · 2013-06-25Phase I Dose Escalation Study to Evaluate the Safety of T138067-Sodium in Patients With Advanced Refractory Cancer